Canakinumab reduces the effects of a substance in the body that can cause inflammation.

Canakinumab is used to treat rare genetic conditions such as Familial Cold Autoinflammatory Syndrome (FCAS) and Muckle-Wells Syndrome (MWS) in adults and children who are at least 4 years old.

Submit your review
1
2
3
4
5
Submit
     
Cancel

Create your own review

Average rating:  
 0 reviews
  • Ilaris
  • More common
    Body aches or pain
    chills
    congestion
    cough
    diarrhea
    dryness or soreness of the throat
    fever
    headache
    hoarseness
    joint pain
    loss of appetite
    muscle aches and pains
    nausea
    shivering
    shortness of breath
    sneezing
    stuffy or runny nose
    sweating
    tender, swollen glands in the neck
    tightness in the chest
    trouble sleeping
    trouble swallowing
    unusual tiredness or weakness
    voice changes
    vomiting
    Severity: Minor
    Some of the side effects that can occur with canakinumab may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:

    More common
    Abdominal or stomach pain
    bleeding, blistering, burning, coldness, discoloration of the skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site
    dizziness or lightheadedness
    feeling of constant movement of self or surroundings
    increased weight
    muscle or bone pain
    sensation of spinning
    weakness
  • (subcutaneous powder for injection)